Regenerative medicine sales will expand through 2036, with cell therapy at 43.8% within the product type segment and orthopedics at 33.4% of the application category in 2026. The market was valued at USD 9.8 billion in 2025 and is forecast to record an 8.4% CAGR between 2026 and 2036.